Nicole Murphy
Net worth: 4 M $ as of 31/05/2026
Net worth: 4 M $ as of 31/05/2026
Nicole Murphy currently works at Biogen, Inc. as Head-Pharmaceutical Operations & Technology since 2022.
Former positions include Executive Director & Head-Supply Chain at Amgen, Inc., Head-Technical Operations & Vice President at Bioverativ, Inc., and General Manager & Head-Cambridge Site Operations at Biogen, Inc. from 2015 to 2016.
Education includes graduate and MBA degrees from Rensselaer Polytechnic Institute and an undergraduate degree from the University of Massachusetts.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BIOGEN INC. 0.01% | 21/04/2026 | 19,749 ( 0.01% ) | 4 M $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| BIOGEN INC. | Chief Operating Officer | 01/02/2022 |
| Companies | Position | End |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01/12/2016 |
| AMGEN INC. | Director/Board Member | - |
| BIOVERATIV INC | Chief Tech/Sci/R&D Officer | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Rensselaer Polytechnic Institute
Rensselaer Polytechnic Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Massachusetts
University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bioverativ, Inc.
Bioverativ, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in discovery, research, development and commercialization of therapies for hemophilia & blood disorders | Health Technology |
Select your edition
All financial news and data tailored to specific country editions